PFM:ARCA-PowerShares Dividend Achievers

ETF | Others | NYSE Arca

Last Closing

USD 29.34

Change

+0.03 (+0.10)%

Market Cap

USD 0.29B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the NASDAQ US Broad Dividend AchieversTM Index. The fund generally will invest at least 90% of its total assets in common stocks of companies that comprise the underlying index. The NASDAQ OMX Group, Inc. includes common stock in the underlying index pursuant to a proprietary selection methodology that identifies a universe of "Dividend AchieversTM."

Inception Date: 15/09/2005

Primary Benchmark: NASDAQ US Broad Div Achievers TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.55%

Management Expense Ratio: 0.54 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
CVE Cenovus Energy Inc 2.12 %
EMMA Emmaus Life Sciences Inc 2.08 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF 0.00 %

-0.84 (-0.48%)

USD 22.00B
ACWI iShares MSCI ACWI ETF 0.00 %

-0.33 (-0.31%)

USD 19.51B
IBIT iShares Bitcoin Trust 0.00 %

+0.45 (+1.24%)

USD 17.74B
CGABL The Carlyle Group Inc. 4.625% .. 0.00 %

-0.19 (-1.00%)

USD 16.14B
JEPQ JPMorgan Nasdaq Equity Premium.. 0.00 %

-0.29 (-0.56%)

USD 11.73B
TBIL Rbb Fund Inc - Us Treasury 3 M.. 0.00 %

+0.01 (+0.02%)

USD 3.07B
IBTE iShares iBonds Dec 2024 Term T.. 0.00 %

+0.02 (+0.06%)

USD 2.86B
IBTF iShares iBonds Dec 2025 Term T.. 0.00 %

N/A

USD 2.25B
USCL iShares Climate Conscious & Tr.. 0.00 %

-0.33 (-0.54%)

USD 2.01B
RILYT B. Riley Financial Inc. 6.00% .. 0.00 %

N/A

USD 1.95B

ETFs Containing PFM

PSY:CA 0.00 % 0.76 %

N/A

N/A
PSY-U:CA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.79% 74% C 66% D+
Dividend Return 1.05% 44% F 39% F
Total Return 19.84% 75% C 66% D+
Trailing 12 Months  
Capital Gain 11.69% 93% A 81% B-
Dividend Return 2.12% 50% F 51% F
Total Return 13.81% 93% A 82% B
Trailing 5 Years  
Capital Gain 39.33% 76% C+ 63% D
Dividend Return 11.39% 63% D 49% F
Total Return 50.72% 76% C+ 63% D
Average Annual (5 Year Horizon)  
Capital Gain 6.19% 71% C- 58% F
Dividend Return 8.31% 64% D 58% F
Total Return 2.12% 57% F 53% F
Risk Return Profile  
Volatility (Standard Deviation) 7.10% 71% C- 92% A
Risk Adjusted Return 117.04% 86% B+ 96% N/A
Market Capitalization 0.29B 67% D+ 49% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.